CAS: 161753-49-7; 12-Oxocalanolide A

结构式图片

上下游产品

5-Hydroxy-6-((2R,3R)-3-hydroxy-2-methyl-butyryl)-2,2-dimethyl-10-propyl-2H-pyrano[2,3-f]chromen-8-one -10-propyl-2H,8H-benzodipyran-8-one5-Hydroxy-2,2-dimethyl-6-(E)-2-methylbut-2-enoyl-10-propyl-2H,8H-benzo1,2-b:3,4-b'dipyran-8-one 3,3-dimethyl acrylaldehyde f]chromene-2,10-dione5-hydroxy-8,9-dimethyl-4-propyl-8,9-dihydro-pyrano[2,3-f]chromene-2,10-dione 86HI-D86 (10S,11S)-10,11-dihydro-4-propyl-6,6,10,11-tetramethyl-2H,6H,12H-benzo[1,2-b;3,4-b';5,6-b'']tripyran-2,12-dione (+)-calanolide A 7,8-dihydro-(-)-calanolide B

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-6777562-B1
    优先权日:2003-02-19
    标 题:Preparation of a trans-calanolide ketone intermediate and chiral separation of calanolide alcohols to give racemic calanolide A
    发明人:DAUGS EDWARD D
    权利人:DOW GLOBAL TECHNOLOGIES INC
    摘要:The method of the invention comprises a process for synthesizing a trans-calanolide A ketone intermediate used in the synthesis of racemic trans-calanolide A. The invention further comprises a method for removing a racemic calanolide B diastereomer from a mixture of calanolide A and calanolide B diastereomers formed in the last step of the synthesis of calanolide A by crystallization.

    专利号:US-6420571-B2
    优先权日:1999-04-26
    标 题:Methods for preparing antiviral calanolide compounds
    发明人:XU ZE-QI; YUAN HONGWEI; CRABB JENNIFER; SAMY RAGHU; LI AILING; CAO HUA
    权利人:SARAWAK MEDICHEM PHARMACEUTICALS INC
    摘要:The present invention relates to methods for preparing 2,2-dimethyl-5-acyloxy -10-propyl-2H,8H-benzo[1,2-b:3,4-b']dipyran-8-one (5) and 2,2-dimethyl-5-hydroxy-10 -propyl-2H,8H-benzo[1,2-b:3,4-b']dipyran-8-one (6) and their use as intermediates for the synthesis of antiviral calanolide compounds. For example, Fries rearrangement on compound 5 or Friedel-Crafts reaction on 6, yields intermediate 2,2-dimethyl-5-hydroxy -6-propionyl-10-propyl-2H,8H-benzo[1,2-b:3,4-b']dipyran-8-one (4), which, in turn, can be converted to (+)-calanolide A and (-)-calanolide B. The coupling of compound 6 with the appropriate chiral molecule under Mitsunobu or nucleophilic displacement leads to the asymmetric synthesis of antiviral calanolide compounds.

    专利号:US-2004106808-A1
    优先权日:2000-12-22
    标题:Processes for preparing calanolide a and intermediates thereof
    发明人:TERASHIMA SHIRO; KOYAKUMARU KENICHI
    摘要:The present invention provides a production method of Calanolide A according to the following method n n n wherein each symbol is as defined in the specification, as a more convenient and industrially practical method for the synthesis of Calanolide A from an easily available starting material.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1177/095632020001100102
    摘要:Xu ZQ, Kern ER, Westbrook L, Allen LB, Buckheit RW, Tseng CK, Jenta T, Flavin MT. Plant-derived and semi-synthetic calanolide compounds with in vitro activity against both human immunodeficiency virus type 1 and human cytomegalovirus. Antivir Chem Chemother. 2000 Jan;11(1):23–9. doi: 10.1177/095632020001100102.
    参考文献:10.1021/jm9602827
    摘要:Galinis DL, Fuller RW, McKee TC, Cardellina JH, Gulakowski RJ, McMahon JB, Boyd MR. Structure-activity modifications of the HIV-1 inhibitors (+)-calanolide A and (-)-calanolide B. J Med Chem. 1996 Oct 25;39(22):4507–10. doi: 10.1021/jm9602827.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知